Picture of PolyPeptide AG logo

PPGN PolyPeptide AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Brief: PolyPeptide Not To Propose Dividend To The Upcoming AGM

March 12 (Reuters) - POLYPEPTIDE GROUP AG  PPGN.S :
    * POLYPEPTIDE WITH RECORD REVENUE GROWTH OF 43% IN H2 2023
VERSUS
H1 2023; OPERATIONAL IMPROVEMENTS YIELDING INCREASED
PROFITABILITY AND CASH FLOW
    * GROSS PROFIT IN 2023 WAS EUR 9.1 MILLION
    * IT EXPECTS REVENUE GROWTH IN 2024 MID TO HIGH SINGLE-DIGIT
AT
CONSTANT CURRENCY RATES VERSUS 2023 WITH A POSITIVE EBITDA,
OPERATING AT A NET LOSS
    * 2024 CAPITAL EXPENDITURE IS EXPECTED TO BE BETWEEN EUR 60
MILLION AND EUR 70 MILLION
    * POLYPEPTIDE IS CURRENTLY PREPARING ITS MID-TERM OUTLOOK,
WHICH
IT PLANS TO PUBLISH ON 13 AUGUST 2024
    * WITH THE NET LOSS REPORTED FOR 2023, THE GROUP WILL NOT BE
PROPOSING THE PAYMENT OF A DIVIDEND  TO THE UPCOMING ANNUAL
GENERAL MEETING ON 10 APRIL 2024

Source text for Eikon:  ID:nEQbjXmhca 
Further company coverage:  PPGN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on PolyPeptide AG

See all news